New progestagens for contraceptive use. (Q34468158)

2 August 2017

1 reference

title

New progestagens for contraceptive use. (English)

1 reference

2 August 2017

Regine Sitruk-Ware

1

1 reference

2 August 2017

16 November 2005

1 reference

Human Reproduction Update

2 August 2017

1 reference

2 August 2017

12

1 reference

2 August 2017

2

1 reference

2 August 2017

169-178

1 reference

Growth inhibition of MCF-7 human breast cancer cells by progesterone is associated with cell differentiation and phosphorylation of Akt protein

2 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Effect of trimegestone alone or in combination with estradiol on bone mass and bone turnover in an adult rat model of osteopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Ovarian function during use of vaginal rings delivering three different doses of Nestorone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Progestogen-only contraception in women at high risk of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

One year contraception with a single subdermal implant containing nomegestrol acetate (Uniplant).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Effects of a progestogen on normal human breast epithelial cell apoptosis in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Hormonal profile, endometrial histology and ovarian ultrasound assessment during 1 year of nomegestrol acetate implant (Uniplant).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Conception and pharmacodynamic profile of drospirenone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Role of progestins in contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Cardiovascular disease and combined oral contraceptives: reviewing the evidence and balancing the risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Potency and pharmacokinetics of gestagens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

The novel progestin drospirenone and its natural counterpart progesterone: Biochemical profile and antiandrogenic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Clinical experience with trimegestone as a new progestin in HRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

The in vivo glucocorticoid and antiglucocorticoid actions of medroxyprogesterone acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Safety of a new oral contraceptive containing drospirenone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Third generation oral contraceptives and risk of venous thrombosis: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Drospirenone: pharmacology and pharmacokinetics of a unique progestogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Comparative pharmacology of newer progestogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Effects of progestogens on haemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Nestorone: a progestin with a unique pharmacological profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Coactivator/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Rat uterine complement C3 expression as a model for progesterone receptor modulators: characterization of the new progestin trimegestone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

The contraceptive vaginal ring (NuvaRing) and hemostasis: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Physical evaluation of a new patch made of a progestomimetic in a silicone matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Oral contraceptives and the risk of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

The pharmacological profile of a novel norpregnance progestin (trimegestone).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Dihydrospirorenone (ZK30595): a novel synthetic progestagen--characterization of binding to different receptor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Classification and pharmacology of progestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Androgens and antiandrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

New progestogens: a review of their effects in perimenopausal and postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Exogenous progestagens and the human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Nestorone: clinical applications for contraception and HRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Effect of dienogest-containing oral contraceptives on lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Effect of four oral contraceptives on hemostatic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

The preclinical biology of a new potent and selective progestin: trimegestone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

Comparison of effects of different combined oral-contraceptive formulations on carbohydrate and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

In vitro characterization of trimegestone: a new potent and selective progestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMI046

21 January 2018

Identifiers

DOI

10.1093/HUMUPD/DMI046

1 reference

2 August 2017

1 reference

PubMed ID

16291771